Form 13F-HR CHI Advisors LLC For: Mar 31

May 16, 2022 3:06 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

Report for the Calendar Year or Quarter Ended: 03-31-2022
Check here if Amendment   Amendment Number:
This Amendment (Check only one.):   is a restatement.
  adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: CHI Advisors LLC
Address: 599 Lexington Avenue
20th Floor
NEW YORK , NY10022
Form 13F File Number: 028-19612

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name: Andrea J.S. Sayago
Title: Chief Compliance Officer
Phone: 212-201-4829
Signature, Place, and Date of Signing:
/s/ Andrea J.S. Sayago New York , NY 05-16-2022
[Signature] [City, State] [Date]
Report Type (Check only one.):
X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
  13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
  13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)
Form 13F Summary Page
Report Summary:
Number of Other Included Managers: 0
Form 13F Information Table Entry Total: 22
Form 13F Information Table Value Total: 235,165
(thousands)
List of Other Managers Reporting for this Manager:
[If there are no entries in this list, omit this section.]
Form 13F File Number Name

List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state “NONE” and omit the column headings and list entries.]
No. Form 13F File Number Name

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
2SEVENTY BIO INC COMMON STOCK 901384107 13,984 819,672 SH DFND 819,672 0 0
AKOUOS INC COM 00973J101 3,972 836,120 SH DFND 836,120 0 0
COMPASS THERAPEUTICS INC COM 20454B104 3,877 2,829,712 SH DFND 2,829,712 0 0
CORVUS PHARMACEUTICALS INC COM 221015100 2,793 1,703,137 SH DFND 1,703,137 0 0
CULLINAN ONCOLOGY INC COM 230031106 28,824 2,753,047 SH DFND 2,753,047 0 0
FREELINE THERAPEUTICS HLDGS SPONSORED ADS 35655L107 5,446 4,862,319 SH DFND 4,862,319 0 0
G1 THERAPEUTICS INC COM 3621LQ109 3,714 488,635 SH DFND 488,635 0 0
IKENA ONCOLOGY INC COM 45175G108 4,970 814,755 SH DFND 814,755 0 0
INOZYME PHARMA INC COM 45790W108 3,649 892,057 SH DFND 892,057 0 0
KEROS THERAPEUTICS INC COM 492327101 3,384 62,229 SH DFND 62,229 0 0
KEZAR LIFE SCIENCES INC COM 49372L100 5,229 314,612 SH DFND 314,612 0 0
LARIMAR THERAPEUTICS INC COM 517125100 6,136 1,515,148 SH DFND 1,515,148 0 0
OMEGA THERAPEUTICS INC COMMON STOCK 68217N105 6,589 1,055,882 SH DFND 1,055,882 0 0
ONCORUS INC COM 68236R103 4,303 2,417,436 SH DFND 2,417,436 0 0
ORCHARD THERAPEUTICS PLC ADS 68570P101 3,779 5,307,751 SH DFND 5,307,751 0 0
OVID THERAPEUTICS INC COM 690469101 2,678 852,888 SH DFND 852,888 0 0
PLIANT THERAPEUTICS INC COM 729139105 18,629 2,657,457 SH DFND 2,657,457 0 0
PRECISION BIOSCIENCES INC COM 74019P108 1,868 606,629 SH DFND 606,629 0 0
PROMETHEUS BIOSCIENCES INC COM 74349U108 59,853 1,585,096 SH DFND 1,585,096 0 0
REPARE THERAPEUTICS INC COM 760273102 36,755 2,581,097 SH DFND 2,581,097 0 0
SPDR SER TR S&P BIOTECH 78464A870 206 222,500 SH Put DFND 222,500 0 0
VECTIVBIO HLDG AG ORD SHS H9060V101 14,527 3,084,310 SH DFND 3,084,310 0 0


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings